Huygen K - Search Results

1

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV. McShane H, et al. Among authors: huygen k. Nat Med. 2004 Nov;10(11):1240-4. doi: 10.1038/nm1128. Epub 2004 Oct 24. Nat Med. 2004. PMID: 15502839 Clinical Trial.

2

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.

Vordermeier HM, Rhodes SG, Dean G, Goonetilleke N, Huygen K, Hill AV, Hewinson RG, Gilbert SC. Vordermeier HM, et al. Among authors: huygen k. Immunology. 2004 Jul;112(3):461-70. doi: 10.1111/j.1365-2567.2004.01903.x. Immunology. 2004. PMID: 15196215 Free PMC article.

3

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.

Ndiaye BP, Thienemann F, Ota M, Landry BS, Camara M, Dièye S, Dieye TN, Esmail H, Goliath R, Huygen K, January V, Ndiaye I, Oni T, Raine M, Romano M, Satti I, Sutton S, Thiam A, Wilkinson KA, Mboup S, Wilkinson RJ, McShane H; MVA85A 030 trial investigators. Ndiaye BP, et al. Among authors: huygen k. Lancet Respir Med. 2015 Mar;3(3):190-200. doi: 10.1016/S2213-2600(15)00037-5. Epub 2015 Feb 26. Lancet Respir Med. 2015. PMID: 25726088 Free PMC article. Clinical Trial.

4

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.

Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, Hall GA, Huygen K, Ottenhoff TH, Franken KL, Andersen P, Doherty TM, Kaufmann SH, Grode L, Seiler P, Martin C, Gicquel B, Cole ST, Brodin P, Pym AS, Dalemans W, Cohen J, Lobet Y, Goonetilleke N, McShane H, Hill A, Parish T, Smith D, Stoker NG, Lowrie DB, Källenius G, Svenson S, Pawlowski A, Blake K, Marsh PD. Williams A, et al. Among authors: huygen k. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):29-38. doi: 10.1016/j.tube.2004.09.009. Epub 2005 Jan 20. Tuberculosis (Edinb). 2005. PMID: 15687025

5

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, DeWitt CM, Orme IM, Baldwin S, D'Souza C, Drowart A, Lozes E, Vandenbussche P, Van Vooren JP, Liu MA, Ulmer JB. Huygen K, et al. Nat Med. 1996 Aug;2(8):893-8. doi: 10.1038/nm0896-893. Nat Med. 1996. PMID: 8705859

6

Comparison of IFN-gamma responses to mycobacterial antigens as markers of response to BCG vaccination.

Weir RE, Fine PE, Floyd S, Stenson S, Stanley C, Branson K, Britton WJ, Huygen K, Singh M, Black G, Dockrell HM. Weir RE, et al. Among authors: huygen k. Tuberculosis (Edinb). 2008 Jan;88(1):31-8. doi: 10.1016/j.tube.2007.10.001. Tuberculosis (Edinb). 2008. PMID: 18277396

7

Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG.

Vordermeier HM, Huygen K, Singh M, Hewinson RG, Xing Z. Vordermeier HM, et al. Among authors: huygen k. Infect Immun. 2006 Feb;74(2):1416-8. doi: 10.1128/IAI.74.2.1416-1418.2006. Infect Immun. 2006. PMID: 16428796 Free PMC article.

8

Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85.

Malin AS, Huygen K, Content J, Mackett M, Brandt L, Andersen P, Smith SM, Dockrell HM. Malin AS, et al. Among authors: huygen k. Microbes Infect. 2000 Nov;2(14):1677-85. doi: 10.1016/s1286-4579(00)01323-x. Microbes Infect. 2000. PMID: 11137041 Free article.

9

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.

Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A, Hitt M, Xing Z. Wang J, et al. Among authors: huygen k. J Immunol. 2004 Nov 15;173(10):6357-65. doi: 10.4049/jimmunol.173.10.6357. J Immunol. 2004. PMID: 15528375

10

Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells.

Smith SM, Malin AS, Pauline T, Lukey, Atkinson SE, Content J, Huygen K, Dockrell HM. Smith SM, et al. Among authors: huygen k. Infect Immun. 1999 Oct;67(10):5223-30. doi: 10.1128/IAI.67.10.5223-5230.1999. Infect Immun. 1999. PMID: 10496899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters